Skip to main content
Figure 3 | BMC Endocrine Disorders

Figure 3

From: The weight lowering effect of sibutramine and its impact on serum lipids in cardiovascular high risk patients with and without type 2 diabetes mellitus - an analysis from the SCOUT lead-in period

Figure 3

The effects of T2D and 1 kg/m 2 BMI-decrement in patients with/without T2D on predicted lipid changes. Multivariable regression analysis demonstrating the effects of a 1 kg/m2 BMI decrement in patients with/without T2D and the effect of T2D on predicted lipid changes. The model is adjusted for all covariates in Table 1. 13 patients with unknown risk category were excluded.

Back to article page